These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8516379)
1. Muscarinic cholinoceptor subtypes in the rat frontoparietal cortex after ipsilateral lesions of the nucleus basalis magnocellularis. Bronzetti E; Caporali MG; Felici L; Niglio T; Scotti de Carolis A; Amenta F Pharmacology; 1993 Jun; 46(6):301-7. PubMed ID: 8516379 [TBL] [Abstract][Full Text] [Related]
2. Effects of nucleus basalis lesion on muscarinic receptor subtypes. Bogdanovic N; Islam A; Nilsson L; Bergström L; Winblad B; Adem A Exp Brain Res; 1993; 97(2):225-32. PubMed ID: 8150042 [TBL] [Abstract][Full Text] [Related]
3. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex. Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399 [TBL] [Abstract][Full Text] [Related]
4. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions. Rossner S; Schliebs R; Bigl V Brain Res; 1994 Dec; 668(1-2):85-99. PubMed ID: 7704621 [TBL] [Abstract][Full Text] [Related]
5. Increase of muscarinic receptor following kainic acid lesions of the nucleus basalis magnocellularis in rat brain: an autoradiographic study. Katayama S; Kito S; Yamamura Y Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):391-4. PubMed ID: 2385763 [TBL] [Abstract][Full Text] [Related]
6. [Subtypes of muscarinic acetylcholine receptor following the experimental denervation of the cholinergic pathway ascending to the neocortex]. Pascual-Alonso T; González-Zárate JL Arch Neurobiol (Madr); 1992; 55(3):116-23. PubMed ID: 1497416 [TBL] [Abstract][Full Text] [Related]
7. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. Ehlert FJ; Tran LP J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898 [TBL] [Abstract][Full Text] [Related]
8. Alterations in cortical muscarinic receptors following cholinotoxin (AF64A) lesion of the rat nucleus basalis magnocellularis. Dawson VL; Hunt ME; Wamsley JK Neurobiol Aging; 1992; 13(1):25-32. PubMed ID: 1347402 [TBL] [Abstract][Full Text] [Related]
9. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE; Ramkumar V; Lai WS J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [TBL] [Abstract][Full Text] [Related]
10. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study. Tonnaer JA; Ernste BH; Wester J; Kelder K J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343 [TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert. Vige X; Briley M Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681 [TBL] [Abstract][Full Text] [Related]
12. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis. Lapchak PA; Araujo DM; Pasinetti G; Hefti F Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970 [TBL] [Abstract][Full Text] [Related]
13. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat. Barbelivien A; Vaussy C; Marchalant Y; Maubert E; Bertrand N; Beley A; Roussel S; Mackenzie ET; Dauphin F J Cereb Blood Flow Metab; 2004 Nov; 24(11):1255-66. PubMed ID: 15545921 [TBL] [Abstract][Full Text] [Related]
14. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis. Shinoda M; Miyazaki A; Toide K Behav Brain Res; 1999 Feb; 99(1):17-25. PubMed ID: 10512568 [TBL] [Abstract][Full Text] [Related]
15. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
16. Effect of lesions of the nucleus basalis magnocellularis and of treatment with posatirelin on cholinergic neurotransmission enzymes in the rat cerebral cortex. Sabbatini M; Coppi G; Maggioni A; Olgiati V; Panocka I; Amenta F Mech Ageing Dev; 1998 Aug; 104(2):183-94. PubMed ID: 9792196 [TBL] [Abstract][Full Text] [Related]
17. Effect of the thyrotropin releasing hormone analogue posatirelin (RGH 2202) on microanatomical changes induced by lesions of the nucleus basalis magnocellularis in the rat. Panocka I; Coppi G; Maggioni A; Olgiati V; Sabbatini M; Amenta F Drugs Exp Clin Res; 1997; 23(1):13-23. PubMed ID: 9093818 [TBL] [Abstract][Full Text] [Related]
18. Microanatomical and electrophysiological changes of the rat dentate gyrus caused by lesions of the nucleus basalis magnocellularis. Panocka I; Sagratella S; Scotti de Carolis A; Zeng YC; Amenta F Neurosci Lett; 1995 May; 190(3):207-11. PubMed ID: 7637894 [TBL] [Abstract][Full Text] [Related]
19. Effect of vagal autotransplantation and bifemelane hydrochloride on cholinergic markers and event-related potentials in rats with lesions of the nucleus basalis magnocellularis. Ikeda K; Egashira T; Yamashita J; Okoyama S Brain Res; 1995 Aug; 688(1-2):171-83. PubMed ID: 8542304 [TBL] [Abstract][Full Text] [Related]
20. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats. Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]